Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02984059 · ClinicalTrials.gov registry record
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
A clinical trial, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
NCT02984059: Completed study, sponsored by Connecticut Children's Medical Center.
NCT02984059 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02984059 has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics. The investigators hypothesize that by using patient pain and psychological assessments in addition to analysis of blood, stool and colonic biopsies, we can better characterize factors that predispose children and adolescents with IBD to have persistent and/or disproportionate abdominal pain.
Primary Outcome
Changes in abdominal pain from baseline then assessed again at 3, 6, 9, and 12 months.
Interventions
- GENETIC RNA analysis
- GENETIC Genomic DNA
- GENETIC Microbiome
- OTHER Calprotectin
- OTHER Pain questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2015-10-21 |
| Est. Completion | 2018-08-01 |
What the finished NCT02984059 record still lists
NCT02984059 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which RNA analysis is the first listed.
NCT02984059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02984059 about?
NCT02984059 is a clinical study titled "Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease". To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics. The investigators hypothesize that by using patient pain and psychological assessments in addition to ana...
What is the current status of trial NCT02984059?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2015-10-21. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT02984059?
The interventions under investigation include: RNA analysis (GENETIC), Genomic DNA (GENETIC), Microbiome (GENETIC), Calprotectin (OTHER), Pain questionnaires (OTHER).
Who is sponsoring clinical trial NCT02984059?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI